John W. Huemoeller II - 15 Mar 2024 Form 4 Insider Report for AXIM BIOTECHNOLOGIES, INC. (AXIM)

Role
Chief Executive Officer, Director
Signature
/s/ John W. Huemoeller II
Issuer symbol
AXIM
Transactions as of
15 Mar 2024
Net transactions value
+$250,000
Form type
4
Filing time
19 Mar 2024, 19:14:19 UTC
Previous filing
23 Sep 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AXIM Convertible Note Award $250,000 +1 +0% $250000.00* 42,500,000 15 Mar 2024 Common Stock 12,500,000 $0.0200 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Reporting Person acquired a convertible note, face value $250,000. The note is convertible into shares of Issuer's common stock at a price of $0.02 per share.